![Alveolus Bio’s Founder, Dr. Vivek Lal, to Present at BIO CEO & Investor Conference](https://alveolusbio.com/wp-content/uploads/2022/02/luke-stackpoole-xs9ZT_ldwPI-unsplash-1080x675.jpg)
![Alveolus Bio’s Founder, Dr. Vivek Lal, to Present at BIO CEO & Investor Conference](https://alveolusbio.com/wp-content/uploads/2022/02/luke-stackpoole-xs9ZT_ldwPI-unsplash-1080x675.jpg)
Recent Posts
- Alveolus Bio’s Founder, Dr. Vivek Lal, to Present at BIO CEO & Investor Conference
- Alveolus Bio to Present at Biotech Showcase 2022
- Neutrophilic inflammation during lung development disrupts elastin assembly and predisposes adult mice to COPD (2021)
- Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia (2018)
- The Airway Microbiome at Birth (2016)
Recent Comments